• HOME
  • SIGN UP
  • LOGIN
  • KALC

대한폐암학회

D-127 Today 2025-07-02

  • SIGN UP
  • LOGIN
  • KALC 2025
    • Invitation
    • Overview
    • Committee
    • Venue
    • News&Notice
    • Past KALC
  • PROGRAM
    • Program at a Glance
    • Scientific Program
    • E-poster
    • Invited Faculty
  • SUBMISSION
    • Abstract Submission
    • Presentation Guidelines
    • Awards
  • ATTENDANCE
    • Registration
    • Transportation
    • Accommodation
    • More about Seoul
    • Visa
  • SPONSORSHIP
    • Sponsorship Opportunities
    • Our Sponsors

D-127 Today 2025-07-02

KALC 2025 INTERNATIONAL CONFERENCE NOVEMBER 7THU ~ 8FRI, 2025 LOTTE HOTEL WORLD, SEOUL, KOREA

HOME
  • ATTENDANCE
    • KALC 2025
    • PROGRAM
    • SUBMISSION
    • ATTENDANCE
    • SPONSORSHIP
    • SIGN UP
  • Accommodation
    • Registration
    • Transportation
    • Accommodation
    • More about Seoul
    • Visa
  • Registration
  • Transportation
  • Accommodation
  • More about Seoul
  • Visa

Accommodation

to be updated

To be Updated

Korean Association for Lung Cancer

#1322, Rosedale Officetel, 280, Gwangpyeong-ro, Gangnam-gu, Seoul, 06367, Korea

E-mail. kalc@lungca.or.kr  Tel. +82-2-741-8540

KALC 2025 Secretariat

General & Registration

E-mail. kalcic@innon.co.kr  T. +82-2-6411-7378

Abstract & Program

E-mail. scientific.kalcic@innon.co.kr  T. +82-2-6411-7318

Copyright © Korean Association for Lung Cancer. All Rights Reserved.

사전등록 양식을 작성하는 모습

25년도 대한폐암학회 연회비를 납부하셔야 회원가로 등록이 가능합니다. 연회비 납부하시겠습니까?

회비 납부하기 비회원으로 등록하기

Oral Presentation 1

  • November 7 (Thu), 14:45-15:45
  • ROOM C (Grand Ballroom 1)
Oral Present
Abstract No. Presentation Time Abstract Title Presenter Name Affiliation Country
A-0186 14:45-14:55 Spatial transcriptomics reveals spatially diverse cancer-associated fibroblasts in lung squamous cell carcinoma linked to tumor progression Kwon Joong Na Seoul National University Korea
A-0184 14:55-15:05 Single-cell RNA sequencing revealed that changes in monocytes are involved in the prognosis of durvalumab consolidation therapy following chemoradiotherapy Duk Ki Kim Chungnam National University Korea
A-0105 15:05-15:15 Landscape of tumor heterogeneity and tumor mutational burden (TMB) in non-small cell lung cancer (NSCLC) Jong Yeob Kim Feinberg School of Medicine, Northwestern University USA
A-0127 15:15-15:25 Induction of malignant transformation in human bronchial epithelial cells and lung organoids by chronic exposure to whole cigarette smoke extract Joo-Eun Lee Chungnam National University Korea
A-0057 15:25-15:35 Identification of GREM-1 and GAS6 as specific biomarkers for cancer-associated fibroblasts derived from patients with non-small cell lung cancer Bo-Guen Kim Kangbuk Samsung Medical Center Korea
A-0042 15:35-15:45 Spatially defined co-culture model of non-small cell lung cancer organoids and cancer-associated fibroblasts to investigate phenotypic heterogeneity Cheol-Kyu Park Chonnam National University Korea

Oral Presentation 2

  • November 8 (Fri), 09:10-10:10
  • ROOM C (Grand Ballroom 1)
Oral Present
Abstract No. Presentation Time Abstract Title Presenter Name Affiliation Country
A-0226 09:10-09:20 Perioperative outcomes of neoadjuvant chemoimmunotherapy followed by surgery in stage II-III NSCLC: A real-world study Junghee Lee Samsung Medical Center Korea
A-0214 09:20-09:30 Preliminary analysis of lazertinib consolidation therapy in patients with locally advanced, unresectable, EGFR mutated NSCLC following chemoradiation therapy: PLATINUM trial Sung Yong Lee Korea University Korea
A-0204 09:30-09:40 What Is the Optimal Dose and Fractionation Schedule for Inoperable Node-Negative Large (>5 cm) Non-Small Cell Lung Cancer? Ye Jin Yoo Asan Medical Center Korea
A-0108 09:40-09:50 Double lung transplantation in patients with metastatic lung-limited non-small cell lung carcinoma (NSCLC): A case series Young Chae Northwestern University Feinberg School of Medicine USA
A-0069 09:50-10:00 Normal brain-sparing radiotherapy versus whole brain radiotherapy for multiple brain metastasis from non-small cell lung cancer Sangjoon Park Severance Hospital Korea
A-0046 10:00-10:10 Refining patient selection for prophylactic cranial irradiation in limited-stage small-cell lung cancer: Insights from a Korean multi-institutional cohort study Hye In Lee Asan Medical Center Korea

Oral Presentation 3

  • November 8 (Fri), 10:25-11:25
  • ROOM C (Grand Ballroom 1)
Oral Present
Abstract No. Presentation Time Abstract Title Presenter Name Affiliation Country
A-0080 10:25-10:35 Real-world insights: Treatment patterns and overall survival in patients with small-cell lung cancer in South Korea a single center experience Sehhoon Park Samsung Medical Center, Sungkyunkwan University School of Medicine Korea
A-0196 10:35-10:45 AI-powered pathologic response evaluation of post-neoadjuvant chemoimmunotherapy in NSCLC patients Kwon Joong Na Seoul National University Korea
A-0167 10:45-10:55 Enhanced thrombopoiesis supplies PD-L1 to circulating immune cells via the generation of PD-L1-Expressing platelets in lung cancer patients Jae Ho Cho Chonnam National University Medical School Korea
A-0230 10:55-11:05 Chemotherapy plus immune checkpoint inhibitors in non-small cell lung cancer with actionable gene alterations other than EGFR, ALK, and ROS1 Ji Eun Shin The Catholic University of Korea St. Vincent's Hospital Korea
A-0131 11:05-11:15 Sequential hypofractionated radiotherapy followed by anti-PD-L1 atezolizumab for recurrent or refractory small cell lung cancer Yang-Gun Suh National Cancer Center Korea
A-0035 11:15-11:25 Imaging trajectory of transformation into small-cell carcinomas from lung adenocarcinomas undergoing TKI treatment: radiomic prediction Jihwan Choi Samsung Medical Center Korea

Basic & Translational Research / Biology / Pathology

Oral Present
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0215 PE1-01 Engineering precision medicine for lung cancer: Antibody-mimetic scaffolds targeting EGFR Tushar Kushwaha All Institute of Medical Sciences India
A-0128 PE1-02 TP53 mutations in Belarusian patients with non-small cell lung cancer Hanna Shchayuk Institute of Genetics and Cytology, National Academy of Sciences of Belarus Belarus
A-0109 PE1-03 Optimized exosomal miRNA panels for early detection of non-small cell lung cancer Da Hyun Kang Chungnam National University Korea
A-0060 PE1-04 Anticancer effect of Columbianadin against benzopyreneinduced lung cancer in rats: Role of PI3K/Akt/FoxO1 and inflammatory pathway Vikas Kumar Sam Higginbottom University of Agriculture, Technology & Sciences India
A-0047 PE1-05 Role of exosomal proteins in brain-specific metastasis of lung cancer Dong Ha Kim Asan Medical Center Korea
A-0238 PE1-06 The influence of knowledge and attitudes on smoking decisions: Case study of the Pandeyan Boyolai village community, Central Java. Rinita Istiqomah Yogyakarta State University Indonesia
A-0237 PE1-07 Driver genes expression and fusions in patients with lung cancer Yuliya Stankevich Institute of Genetics and Cytology of the National Academy of Sciences of Belarus Belarus
A-0233 PE1-08 Association between long non-coding RNA HOTAIR polymorphism and lung cancer risk: A meta-analysis Farhana Sultana Mitu Islamic University Bangladesh
A-0232 PE1-09 A meta-analytic approach to find the association between polymorphism with in MicroRNAs and lung cancer risk Md Abdullah Al Maruf Islamic University Bangladesh
A-0228 PE1-10 CTSC regulates cell growth in small cell lung cancer via YAP/PAR2 signaling pathway Nayoung Kim Chungnam National University Hospital Korea
A-0208 PE1-11 Lung Organoid to understand mechanism of therapeutic resistance in lung cancer Jinwook Choi School of Life Sciences, Gwangju Institute of Science and Technology (gist) Korea
A-0185 PE1-13 The impact of Living-Donor Lobar Lung Transplantation (LDLLT) procedure on the sexual function of donors and recipients: A systematic review Rosinta Hotmaida P Purba The Pranala Institute Indonesia
A-0179 PE1-14 Loss of Cereblon (CRBN) enhances lung cancer cell migration and invasion through regulation of cystathionine -synthase (CBS) Kihun Kim Gwangju Institute of Science and Technology Korea
A-0173 PE1-15 Parallel Accumulation-Serial Fragmentation for in-depth proteomic analysis of bronchoalveolar lavage fluid of non-small cell lung cancer Seung Hyeun Lee Kyung Hee University Medical Center Korea
A-0164 PE1-16 Butanolic fraction of Asparagus racemosus root alters the JAK/STAT3 Signaling Pathway to mitigate metastasis, apoptosis, and proliferation in lung cancer Niti Singh Marlabs Innovation Pvt Ltd. India
A-0161 PE1-17 Utilizing machine learning methodologies to forecast the occurence of lung cancer in patients of central region. Manvendra Singh Hmfa Miet India
A-0160 PE1-18 Solid Lipid Nanoparticle of Ganodric acid in the treatment against benzopyreneinduced lung cancer in rats: Nrf2/HO-1 signaling pathway V Kumar Shalom Institute of Health & Allied Sciences India
A-0156 PE1-19 Solid lipid nanoparticles of gallic acid enhances apoptosis and proliferation in rats to lessen lung cancer induced by diethylnitrosamine/2-acetylaminofluorene. Deepika Singh Shuats India
A-0154 PE1-20 The incidence of hematologic paraneoplastic syndromes in newly diagnosed lung cancer patients Roland Helmizar Baiturrahmah University Indonesia
A-0114 PE1-22 A pilot study to discover potential early NSCLC biomarkers in the Filipino secretome Josemaria Alejandro Corpuz University of the Philippines-Diliman Philippines
A-0090 PE1-23 Recapitulation tumor microenvionments with lung cancer organoids for drug screening study Insu Lee Seoul National University Bundang Hospital Korea
A-0088 PE1-24 What is our role to reduce lung cancer mortality rates?: Case studies of 7 countries with the highest lung cancer Nadia Fazira Andalas University Indonesia
A-0087 PE1-25 ARAF p.S214C Mutation Enhances Sorafenib Response in Lung Cancer Carol Lee The Chinese University of Hong Kong Hong Kong
A-0076 PE1-27 Enhancing tumoroid applications with regenix in advanced 3D cell culture models Da Hye Song Cellartgen Korea
A-0068 PE1-28 Regenix in lung cancer PDX models: Advancing research and therapeutic potential Da Hye Song Cellartgen Korea
A-0063 PE1-29 Synergistic anticancer effects of Niclosamide and Osimertinib: Repurposing drugs in autophagy for the treatment of EGFR-mutant lung cancer cells Yuan-Ming Tsai Tri-Service General Hospital, National Defense Medical Center Taiwan
A-0051 PE1-30 Identification of Guanine-quadruplex forming DNA aptamer: A promising therapeutic strategy for EGFR overexpressed non-small cell lung cancer Deepa Singh All Institute of Medical Sciences India
A-0050 PE1-31 Austrian biobanking and biomolecular resources research infrastructure - Important partner for research on biological samples Luka Brcic Medical University of Graz Austria
A-0049 PE1-32 Clinical and genomic features of different KRAS Subtypes in non-small cell lung cancer Soo Han Kim Pusan National University Hospital Korea

Big Data & AI

Big Data & AI
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0151 PE1-34 Network pharmacology study revealed the multitargets anticancer mechanism of sesamin in NSCLC Reny Rosalina University of Palangka Raya Indonesia
A-0250 PE1-35 Utilizing machine learning algorithms for enhanced lung cancer diagnosis through imaging biomarkers Divo Helmizar Stan Jakarta Indonesia
A-0239 PE1-36 Deep-learning model for personalized recurrence prediction in early-stage non-small cell lung cancer Daehwan Lee Spidercore Inc. Korea
A-0093 PE1-38 Increased risk of lung cancer in individuals with nontuberculous mycobacterial pulmonary disease: A Korean population-based study Dongwon Park Hanyang University Medical Center Korea
A-0086 PE1-39 Deep-learning-driven prediction of lung cancer recurrence using integrated immune profiling and radiomic features from computed tomography scans Rifaldy Fajar Yogyakarta State University Indonesia

Others

Others
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0064 PE1-40 Harnessing computer-aided drug discovery for the development of potent allosteric inhibitors targeting EGFR in NSCLC Mdaliasif Noor Chonbuk National University Hospital Korea
A-0120 PE1-42 The association between prevalence of tobacco use, nitrous oxide emissions and current health expenditure toward lung cancer in asian countries Devi Yulia Rahmi Universitas Andalas Indonesia
A-0139 PE1-43 Self efficacy and quality of life in lung cancer patients: Systematic reviews Mega Dwi Septivani Padang State Polytechnic Indonesia
A-0166 PE1-44 Revealed intermittent fasting benefit: How does the systematic review suggest lung cancer patients should undergo the most effective fasting? Yesika Simbolon Atmajaya University Indonesia

Pulmonology / Endoscopy

Pulmonology / Endoscopy
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0067 PE1-45 Evaluating the bleeding risk after discontinuation of antiplatelets or anticoagulants in advanced diagnostic bronchoscopy Bora Lee The Catholic University of Korea Eunpyeong St. Mary's Hospital Korea

Radiology / Staging / Screening / Epidemiology

Radiology / Staging / Screening / Epidemiology
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0112 PE1-46 Factors predicting uptake of counseling visit in a national lung cancer screening program in South Korea A Ram Kim University of Ulsan Korea

Early / Locally Advanced Non-Small Cell Lung Cancer

Early / Locally Advanced Non-Small Cell Lung Cancer
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0149 PE2-01 Comparison of overall survival between invasive mucinous and non-mucinous lung adenocarcinoma depending on stage and treatment modalities Youjin Oh John H. Stroger, Jr. Hospital of Cook County Health USA
A-0104 PE2-02 Prognostic impact of mucinous vs. non-mucinous lung adenocarcinoma with lepidic growth pattern: a real-world analysis 22,914 patients from SEER Yujung Heo Feinberg School of Medicine, Northwestern University Korea
A-0134 PE2-03 Integrative proteomic and phosphoproteomic: A pilot study on profiling Filipino non-small cell lung cancer patients Aubrey Mae Lipa University of the Philippines - Diliman Philippines
A-0079 PE2-04 Potential and correlation of PET imaging and immune biomarkers for neoadjuvant immunotherapy in stage II/III non-small cell lung cancer Eun Seong Lee Korea University Guro Hospital Korea
A-0066 PE2-05 Discovering potential biomarkers for diagnosis and prognosis of LUAD NSCLC Baby Rorielyn Dimayacyac-Esleta University of the Philippines-Diliman Philippines
A-0061 PE2-06 Whole blood metabolomic patterns in non-small cell lung cancer: A comparative study with healthy controls Kamal Baswal Phd Student India

Mesothelioma / Thymic & Other Thoracic Malignancies

Mesothelioma / Thymic & Other Thoracic Malignancies
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0126 PE2-07 Pediatric mesothelioma: a case report Heae Surng Park Ewha Womans University Medical Center Korea
A-0125 PE2-08 The impact of prevalence of annual freshwater withdrawals, drinking water services and air pollution toward mesothelioma cancer Ferza Alfath Alumnus Universitas Andalas Indonesia
A-0118 PE2-09 Characterization of tumor-infiltrating B cells in malignant pleural mesothelioma and thymic carcinoma using single-cell RNA sequencing and deep learning Sahnaz Vivinda Putri International University Semen Indonesia
A-0020 PE2-10 Well differentiated papillary mesothelial tumor from retrospective diagnosis for 10 years (2013 - 2023) Nguyen Son Lam Pham Ngoc Thach Hospital Vietnam

Radiotherapy

Radiotherapy
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0242 PE2-12 Clinically significant cardiovascular diseases after postoperative radiotherapy in non-small cell lung cancer: a Korean nationwide cohort study Byoung Hyuck Kim Seoul National University Boramae Medical Center Korea
A-0209 PE2-13 Lung volume reduction as a potential risk factor for symptomatic radiation pneumonitis during concurrent chemoradiotherapy of lung cancer Yun Hee Lee The Catholic University of Korea Bucheon St. Mary's Hospital Korea
A-0183 PE2-14 Radiotherapy for synchronous double primary cancers of lung and prostate: Case report of two patients Seung Gyu Park Keimyung University Dongsan Medical Center Korea
A-0099 PE2-15 Association between antipsychotic drug and survival in patients with lung cancer treated with chemoradiotherapy: A Nationwide Korean Cohort Study Dong-Yun Kim Chung-Ang University Hospital Korea
A-0071 PE2-16 Stereotactic ablative radiotherapy for pulmonary metastasis from sarcoma: A retrospective comparison with metastasectomy Youngju Song Asan Medical Center Korea

Surgery

Surgery
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0155 PE2-17 Double lung transplantation in patients with recent history of malignancy Chan Mi Jung Feinberg School of Medicine, Northwestern University USA
A-0058 PE2-18 Feasibility of wedge resection for peripheral clinical T1bN0 or less non-small cell lung cancer Taeyoung Yun Seoul National University Hospital Korea
A-0092 PE2-19 Analysis of the prognostic impact of tumor necrosis in completely resected stage I and II lung adenocarcinoma Seung Hwan Song Hanyang University Medical Center Korea

Advanced Non-Small Cell Lung Cancer / Chemotherapy / Targeted Therapy / Immunotherapy

Advanced Non-Small Cell Lung Cancer / Chemotherapy / Targeted Therapy / Immunotherapy
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0133 PE3-01 Targeting EGFR and its mutations in peatland fire-induced lung cancer: The therapeutic potential of Kalimantan's endemic plant compounds Amanda Natania Gracia Faculty of Mathematics and Natural Sciences, University of Palangka Raya Indonesia
A-0082 PE3-02 Development of a novel inhibitor against nRAS-mutated lung cancers Vikas Kumar Aiims New Delhi India
A-0059 PE3-03 Health-related quality of life with tepotinib in METex14 skipping NSCLC with brain, liver, adrenal or bone metastases: VISION trial Beung Chul Ahn Research Institute and Hospital of National Cancer Center Korea
A-0252 PE3-04 Unlocking the potential of fasting to optimize chemotherapy outcomes in lung cancer: A bibliometric exploration Fairuz Tsuraya Ramadhani Universitas Palangka Raya Indonesia
A-0224 PE3-05 A study to evaluate the effectiveness of exosomal proteins as biomarkers in non-small cell lung carcinoma Aashal Bhavesh Shah Gmers Medical College and Hospital India
A-0205 PE3-06 Efficacy of Nivolumab in patients with recurrent advanced nonsmall cell lung cancer in Indian population Jatinkumar Veljibhai Dhanani Gmers Medical College, Navsari India
A-0201 PE3-07 Evaluating the efficacy of sequential IL-6 and PD-1 inhibitor treatment in murine lung cancer: Immune modulation and tumor size reduction Soyun Kim Chungnam National University Hospital Korea
A-0169 PE3-08 Delta-He as a novel prognostic biomarker in NSCLC patients treated with PD-1/PD-L1 inhibitors Green Hong Chungnam National University Hospital Korea
A-0157 PE3-09 Bioinformatics identification of potent siRNAs targeting vscular endothelial growth factor receptor and mesenchymal-epithelial transition factor for non-small cell lung cancer Rian Ka Praja Universitas Palangka Raya Indonesia
A-0122 PE3-10 AI-driven predictive model of ALK inhibitor responses merging single-cell RNA sequencing with radiogenomics in advanced non-small cell lung cancer Prihantini Prihantini Bandung Institute of Technology Indonesia
A-0116 PE3-11 Impact of antibiotic exposure on the effectiveness of immune checkpoint inhibitors in patients with non-small cell lung cancer Myeong Geun Choi Ewha Womans University Mokdong Hospital Korea
A-0089 PE3-12 Blood plasma proteomic-based identification and characterization of aberrantly expressed proteins in EGFR TKI resistant late-stage NSCLC patients Ferdinand Mira Institute of Chemistry, University of the Philippines, Diliman Philippines
A-0065 PE3-13 Analysis of clinical characteristics and survival after completion of two years of immune checkpoint inhibitor treatment in advanced NSCLC Kyoungmin Lee Korea University Guro Hospital Korea

Palliative Care

Palliative Care
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0115 PE3-14 Digital aging and mental health deteriorationsof among Indonesian elderly with lung cancer: A psychosocioeconomic analysis Lintong Hottua Simbolon The Pranala Institute Indonesia
A-0256 PE3-15 The significance of music-based interventions in lung cancer patients in palliative care : A bibliometric analysis Mery Enjelica Cristin Universitas Palangka Raya Indonesia
A-0249 PE3-16 Music therapy and spiritual nursing care for lung cancer sufferers in Indonesia post surgery Yusril Yusril Uin Sjech M. Djamil Djambek Bukittinggi Indonesia
A-0241 PE3-17 Palliative care for lung cancer patients: Before and during the COVID-19 pandemic Yusril Yusril Uin Sjech M. Djamil Djambek Bukittinggi Indonesia
A-0213 PE3-18 Quality of life among chronic lung disease patients in Indonesia: Insights from the Indonesia family life survey Derizal Derizal Ip Trisakti Indonesia
A-0207 PE3-19 Analysis of health management of mesothelioma patients in Indonesia, including early diagnosis, treatment, and palliative support. Andi Makkasau Andi Ureng Alami Gsb Indonesia
A-0198 PE3-20 Best nudge to influence people's behaviour for better off: Choices architecture on lung cancer prevention? Helen Try Juniasti Cendrawasih University Indonesia
A-0165 PE3-21 Prevention and treatment of lung disease disease: How community-based health care take the important role among 17k islands in Indonesia Hepri Ardianson Purba The Pranala Institute Indonesia

Small Cell Lung Cancer / Neuroendocrine Tumors

Small Cell Lung Cancer / Neuroendocrine Tumors
Abstract No. Poster No. Abstract Title Presenter Name Affiliation Country
A-0189 PE3-23 Innovative neural network models for analyzing platinum-based chemotherapy effects in extensive-stage small cell lung cancer (ES-SCLC) patients Prihantini Prihantini Bandung Institute of Technology Indonesia
A-0048 PE3-24 Can AI based on morphology provide clinically more meaningful classification of lung neuroendocrine tumours-lungNENomics project results Luka Brcic Medical University of Graz Austria
A-0192 PE3-25 Anti-tumor activity and safety of autologous Vax-NK/HCC consolidation therapy following first-line chemoimmunotherapy in patients with extensive-stage small cell lung cancer In-Jae Oh Chonnam National University Hwasun Hospital Korea
A-0136 PE3-26 Targeting exosomal microRNA signatures for early detection and prognosis of chemoresistant small cell lung cancer: a machine learning-driven approach Elfiany Syafruddin Bulukumba Muhammadiyah University Indonesia